Thalidomide--the way forward.
Gardner-Medwin
J M
JM
Department of Immunology, University Hospital, Queen's Medical Centre, Nottingham, UK.
Powell
R J
RJ
D000014:Abnormalities, Drug-Induced; D004893:Erythema Nodosum / Q000188:drug therapy*; D006801:Humans; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*
D013792:Thalidomide